These findings demonstrate that miR-146a inhibits SEMA3C-induced invasion and proliferation in suspension cells, suggesting the possibility that miR-146a may be an important factor in attenuating breast cancer CTCs. The gene discussed is SEMA3C; the disease is breast cancer.